Anti-Müllerian hormone: an ovarian reserve marker in primary ovarian insufficiency (original) (raw)

• Conway, G. S. Premature ovarian failure. Br. Med. Bull. 56, 643–649 (2000).
  Article CAS PubMed Google Scholar
• Albright, F., Smith, P. H. & Fraser, R. A syndrome characterized by primary ovarian insufficiency and decreased stature: Report of 11 cases with a digression on hormonal control of axillary and pubic hair. Am. J. Med. Sci. 204, 625–648 (1942).
  Article Google Scholar
• Welt, C. K. Primary ovarian insufficiency: a more accurate term for premature ovarian failure. Clin. Endocrinol. (Oxf.) 68, 499–509 (2008).
  Article Google Scholar
• Nelson, L. M. Clinical practice. Primary ovarian insufficiency. N. Engl. J. Med. 360, 606–614 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• De Vos, M., Devroey, P. & Fauser, B. C. Primary ovarian insufficiency. Lancet 376, 911–921 (2010).
  Article PubMed Google Scholar
• te Velde, E. R. & Pearson, P. L. The variability of female reproductive ageing. Hum. Reprod. Update 8, 141–154 (2002).
  Article PubMed Google Scholar
• Coulam, C. B., Adamson, S. C. & Annegers, J. F. Incidence of premature ovarian failure. Obstet. Gynecol. 67, 604–606 (1986).
  CAS PubMed Google Scholar
• Anasti, J. N. Premature ovarian failure: an update. Fertil. Steril. 70, 1–15 (1998).
  Article CAS PubMed Google Scholar
• Persani, L., Rossetti, R. & Cacciatore, C. Genes involved in human premature ovarian failure. J. Mol. Endocrinol. 45, 257–279 (2010).
  Article CAS PubMed Google Scholar
• Matzuk, M. M. & Lamb, D. J. The biology of infertility: research advances and clinical challenges. Nat. Med. 14, 1197–1213 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Bakalov, V. K. et al. Autoimmune oophoritis as a mechanism of follicular dysfunction in women with 46,XX spontaneous premature ovarian failure. Fertil. Steril. 84, 958–965 (2005).
  Article PubMed Google Scholar
• Aittomäki, K. et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 82, 959–968 (1995).
  Article PubMed Google Scholar
• Latronico, A. C. et al. Brief report: testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene. N. Engl. J. Med. 334, 507–512 (1996).
  Article CAS PubMed Google Scholar
• Araki, S. et al. Arrest of follicular development in a patient with 17 alpha-hydroxylase deficiency: folliculogenesis in association with a lack of estrogen synthesis in the ovaries. Fertil. Steril. 47, 169–172 (1987).
  Article CAS PubMed Google Scholar
• Conte, F. A., Grumbach, M. M., Ito, Y., Fisher, C. R. & Simpson, E. R. A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom). J. Clin. Endocrinol. Metab. 78, 1287–1292 (1994).
  CAS PubMed Google Scholar
• Nelson, L. M. et al. Development of luteinized graafian follicles in patients with karyotypically normal spontaneous premature ovarian failure. J. Clin. Endocrinol. Metab. 79, 1470–1475 (1994).
  CAS PubMed Google Scholar
• Nelson, L. M., Covington, S. N. & Rebar, R. W. An update: spontaneous premature ovarian failure is not an early menopause. Fertil. Steril. 83, 1327–1332 (2005).
  Article PubMed Google Scholar
• Hubayter, Z. R. et al. A prospective evaluation of antral follicle function in women with 46, XX spontaneous primary ovarian insufficiency. Fertil. Steril. 94, 1769–1774 (2010).
  Article PubMed Google Scholar
• Karimov, C. B. et al. Increased frequency of occult fragile X-associated primary ovarian insufficiency in infertile women with evidence of impaired ovarian function. Hum. Reprod. 26, 2077–2083 (2011).
  Article CAS PubMed Google Scholar
• Goswami, D. & Conway, G. S. Premature ovarian failure. Hum. Reprod. Update 11, 391–410 (2005).
  Article CAS PubMed Google Scholar
• Skillern, A. & Rajkovic, A. Recent developments in identifying genetic determinants of premature ovarian failure. Sex. Dev. 2, 228–243 (2008).
  Article CAS PubMed Google Scholar
• Knauff, E. A. et al. Genome-wide association study in premature ovarian failure patients suggests ADAMTS19 as a possible candidate gene. Hum. Reprod. 24, 2372–2378 (2009).
  Article CAS PubMed Google Scholar
• van Dooren, M. F., Bertoli-Avellab, A. M. & Oldenburg, R. A. Premature ovarian failure and gene polymorphisms. Curr. Opin. Obstet. Gynecol. 21, 313–317 (2009).
  Article PubMed Google Scholar
• Oldenburg, R. A. et al. A genome-wide linkage scan in a Dutch family identifies a premature ovarian failure susceptibility locus. Hum. Reprod. 23, 2835–2841 (2008).
  Article CAS PubMed Google Scholar
• Christin-Maitre, S. & Tachdjian, G. Genome-wide association study and premature ovarian failure. Ann. Endocrinol. (Paris) 71, 218–221 (2010).
  Article CAS Google Scholar
• Bondy, C. A. Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group. J. Clin. Endocrinol. Metab. 92, 10–25 (2007).
  Article CAS PubMed Google Scholar
• Saenger, P. et al. Recommendations for the diagnosis and management of Turner syndrome. J. Clin. Endocrinol. Metab. 86, 3061–3069 (2001).
  CAS PubMed Google Scholar
• Sherman, S. L. Premature ovarian failure in the fragile X syndrome. Am. J. Med. Genet. 97, 189–194 (2000).
  Article CAS PubMed Google Scholar
• Verkerk, A. J. et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65, 905–914 (1991).
  Article CAS PubMed Google Scholar
• Fu, Y. H. et al. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 67, 1047–1058 (1991).
  Article CAS PubMed Google Scholar
• Allingham-Hawkins, D. J. et al. Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study—preliminary data. Am. J. Med. Genet. 83, 322–325 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Conway, G. S., Payne, N. N., Webb, J., Murray, A. & Jacobs, P. A. Fragile X premutation screening in women with premature ovarian failure. Hum. Reprod. 13, 1184–1187 (1998).
  Article CAS PubMed Google Scholar
• Conway, G. S., Kaltsas, G., Patel, A., Davies, M. C. & Jacobs, H. S. Characterization of idiopathic premature ovarian failure. Fertil. Steril. 65, 337–341 (1996).
  Article CAS PubMed Google Scholar
• Novosad, J. A., Kalantaridou, S. N., Tong, Z. B. & Nelson, L. M. Ovarian antibodies as detected by indirect immunofluorescence are unreliable in the diagnosis of autoimmune premature ovarian failure: a controlled evaluation. BMC Womens Health 3, 2 (2003).
  Article PubMed PubMed Central Google Scholar
• La Marca, A. et al. Primary ovarian insufficiency: autoimmune causes. Curr. Opin. Obstet. Gynecol. 22, 277–282 (2010).
  PubMed Google Scholar
• Gatta, G., Capocaccia, R., Coleman, M. P., Ries, L. A. & Berrino, F. Childhood cancer survival in Europe and the United States. Cancer 95, 1767–1772 (2002).
  Article PubMed Google Scholar
• Gatta, G. et al. Childhood cancer survival trends in Europe: a EUROCARE Working Group study. J. Clin. Oncol. 23, 3742–3751 (2005).
  Article PubMed Google Scholar
• Edgar, A. B., Morris, E. M., Kelnar, C. J. & Wallace, W. H. Long-term follow-up of survivors of childhood cancer. Endocr. Dev. 15, 159–180 (2009).
  Article PubMed Google Scholar
• Bath, L. E., Wallace, W. H. & Critchley, H. O. Late effects of the treatment of childhood cancer on the female reproductive system and the potential for fertility preservation. BJOG 109, 107–114 (2002).
  Article PubMed Google Scholar
• van Dorp, W. et al. Long-term endocrine side effects of childhood Hodgkin's lymphoma treatment: a review. Hum. Reprod. Update http://dx.doi.org/10.1093/humupd/dmr038.
• Brougham, M. F. & Wallace, W. H. Subfertility in children and young people treated for solid and haematological malignancies. Br. J. Haematol. 131, 143–155 (2005).
  PubMed Google Scholar
• Shelling, A. N. Premature ovarian failure. Reproduction 140, 633–641 (2010).
  Article CAS PubMed Google Scholar
• Josso, N. et al. Anti-müllerian hormone: the Jost factor. Recent Prog. Horm. Res. 48, 1–59 (1993).
  CAS PubMed Google Scholar
• Lee, M. M. & Donahoe, P. K. Müllerian inhibiting substance: a gonadal hormone with multiple functions. Endocr. Rev. 14, 152–164 (1993).
  CAS PubMed Google Scholar
• Josso, N., Picard, J. Y. & Tran, D. The anti-Müllerian hormone. Birth Defects Orig. Artic. Ser. 13, 59–84 (1977).
  CAS PubMed Google Scholar
• Durlinger, A. L., Visser, J. A. & Themmen, A. P. Regulation of ovarian function: the role of anti-Müllerian hormone. Reproduction 124, 601–609 (2002).
  Article CAS PubMed Google Scholar
• Rajpert-De Meyts, E. et al. Expression of anti-Müllerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells. J. Clin. Endocrinol. Metab. 84, 3836–3844 (1999).
  PubMed Google Scholar
• Weenen, C. et al. Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol. Hum. Reprod. 10, 77–83 (2004).
  Article CAS PubMed Google Scholar
• Shi, J. et al. Bone morphogenetic protein-6 stimulates gene expression of follicle-stimulating hormone receptor, inhibin/activin beta subunits, and anti-Müllerian hormone in human granulosa cells. Fertil. Steril. 92, 1794–1798 (2009).
  Article PubMed Google Scholar
• Salmon, N. A., Handyside, A. H. & Joyce, I. M. Oocyte regulation of anti-Müllerian hormone expression in granulosa cells during ovarian follicle development in mice. Dev. Biol. 266, 201–208 (2004).
  Article CAS PubMed Google Scholar
• Grøndahl, M. L. et al. Anti-Müllerian hormone remains highly expressed in human cumulus cells during the final stages of folliculogenesis. Reprod. Biomed. Online 22, 389–398 (2011).
  Article CAS PubMed Google Scholar
• McGee, E. A. & Hsueh, A. J. Initial and cyclic recruitment of ovarian follicles. Endocr. Rev. 21, 200–214 (2000).
  CAS PubMed Google Scholar
• Durlinger, A. L. L. et al. Control of primordial follicle recruitment by anti-Müllerian hormone in the mouse ovary. Endocrinology 140, 5789–5796 (1999).
  Article CAS PubMed Google Scholar
• Carlsson, I. B. et al. Anti-Müllerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro. Hum. Reprod. 21, 2223–2227 (2006).
  Article CAS PubMed Google Scholar
• Durlinger, A. L. L. et al. Anti-Müllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology 143, 1076–1084 (2002).
  Article CAS PubMed Google Scholar
• Gigli, I., Cushman, R. A., Wahl, C. M. & Fortune, J. E. Evidence for a role for anti-Müllerian hormone in the suppression of follicle activation in mouse ovaries and bovine ovarian cortex grafted beneath the chick chorioallantoic membrane. Mol. Reprod. Dev. 71, 480–488 (2005).
  Article CAS PubMed Google Scholar
• Kevenaar, M. E. et al. A polymorphism in the AMH type II receptor gene is associated with age at menopause in interaction with parity. Hum. Reprod. 22, 2382–2388 (2007).
  Article CAS PubMed Google Scholar
• Durlinger, A. L. L. et al. Anti-Müllerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology 142, 4891–4899 (2001).
  Article CAS PubMed Google Scholar
• Visser, J. A. et al. Increased oocyte degeneration and follicular atresia during the estrous cycle in anti-Müllerian hormone null mice. Endocrinology 148, 2301–2308 (2007).
  Article CAS PubMed Google Scholar
• di Clemente, N. et al. Inhibitory effect of AMH upon the expression of aromatase and LH receptors of granulosa cells of rat and porcine immature ovaries. Endocrine 2, 553–558 (1994).
  CAS Google Scholar
• Grossman, M. P., Nakajima, S. T., Fallat, M. E. & Siow, Y. Müllerian-inhibiting substance inhibits cytochrome P450 aromatase activity in human granulosa lutein cell culture. Fertil. Steril. 89, 1364–1370 (2008).
  Article CAS PubMed Google Scholar
• Andersen, C. Y. & Byskov, A. G. Estradiol and regulation of anti-Müllerian hormone, inhibin-A, and inhibin-B secretion: analysis of small antral and preovulatory human follicles' fluid. J. Clin. Endocrinol. Metab. 91, 4064–4069 (2006).
  Article CAS PubMed Google Scholar
• Kevenaar, M. E. et al. Anti-Müllerian hormone and anti-Müllerian hormone type II receptor polymorphisms are associated with follicular phase estradiol levels in normo-ovulatory women. Hum. Reprod. 22, 1547–1554 (2007).
  Article CAS PubMed Google Scholar
• te Velde, E. R., Scheffer, G. J., Dorland, M., Broekmans, F. J. & Fauser, B. C. Developmental and endocrine aspects of normal ovarian aging. Mol. Cell. Endocrinol. 145, 67–73 (1998).
  Article CAS PubMed Google Scholar
• Scheffer, G. J. et al. Antral follicle counts by transvaginal ultrasonography are related to age in women with proven natural fertility. Fertil. Steril. 72, 845–851 (1999).
  Article CAS PubMed Google Scholar
• Bergada, I. et al. Time course of the serum gonadotropin surge, inhibins, and anti-Müllerian hormone in normal newborn males during the first month of life. J. Clin. Endocrinol. Metab. 91, 4092–4098 (2006).
  Article CAS PubMed Google Scholar
• Guibourdenche, J. et al. Anti-Müllerian hormone levels in serum from human foetuses and children: pattern and clinical interest. Mol. Cell. Endocrinol. 211, 55–63 (2003).
  Article CAS PubMed Google Scholar
• Hagen, C. P. et al. Serum levels of anti-Müllerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 Turner syndrome patients. J. Clin. Endocrinol. Metab. 95, 5003–5010 (2010).
  Article CAS PubMed Google Scholar
• Lee, M. M. et al. Mullerian inhibiting substance in humans: normal levels from infancy to adulthood. J. Clin. Endocrinol. Metab. 81, 571–576 (1996).
  CAS PubMed Google Scholar
• van Rooij, I. A. et al. Anti-müllerian hormone is a promising predictor for the occurrence of the menopausal transition. Menopause 11, 601–606 (2004).
  Article PubMed Google Scholar
• van Rooij, I. A. et al. Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: A longitudinal study. Fertil. Steril. 83, 979–987 (2005).
  Article CAS PubMed Google Scholar
• de Vet, A., Laven, J. S., de Jong, F. H., Themmen, A. P. N. & Fauser, B. C. Antimüllerian hormone serum levels: a putative marker for ovarian aging. Fertil. Steril. 77, 357–362 (2002).
  Article PubMed Google Scholar
• Fanchin, R. et al. Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum. Reprod. 18, 323–327 (2003).
  Article CAS PubMed Google Scholar
• van Rooij, I. A. et al. Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve. Hum. Reprod. 17, 3065–3071 (2002).
  Article CAS PubMed Google Scholar
• Hansen, K. R., Hodnett, G. M., Knowlton, N. & Craig, L. B. Correlation of ovarian reserve tests with histologically determined primordial follicle number. Fertil. Steril. 95, 170–175 (2011).
  Article PubMed Google Scholar
• Kevenaar, M. E. et al. Serum anti-mullerian hormone levels reflect the size of the primordial follicle pool in mice. Endocrinology 147, 3228–3234 (2006).
  Article CAS PubMed Google Scholar
• Seifer, D. B., Baker, V. L. & Leader, B. Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States. Fertil. Steril. 95, 747–750 (2011).
  Article CAS PubMed Google Scholar
• Kelsey, T. W., Wright, P., Nelson, S. M., Anderson, R. A. & Wallace, W. H. A validated model of serum anti-müllerian hormone from conception to menopause. PLoS ONE 6, e22024 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Nelson, S. M. et al. External validation of nomogram for the decline in serum anti-Müllerian hormone in women: a population study of 15,834 infertility patients. Reprod. Biomed. Online 23, 204–206 (2011).
  Article PubMed Google Scholar
• Hehenkamp, W. J. et al. Anti-Müllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. J. Clin. Endocrinol. Metab. 91, 4057–4063 (2006).
  Article CAS PubMed Google Scholar
• La Marca, A., Stabile, G., Artenisio, A. C. & Volpe, A. Serum anti-Müllerian hormone throughout the human menstrual cycle. Hum. Reprod. 21, 3103–3107 (2006).
  Article CAS PubMed Google Scholar
• Streuli, I. et al. Serum antimüllerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids. Fertil. Steril. 90, 395–400 (2008).
  Article CAS PubMed Google Scholar
• Tsepelidis, S. et al. Stable serum levels of anti-Müllerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women. Hum. Reprod. 22, 1837–1840 (2007).
  Article CAS PubMed Google Scholar
• Robertson, D. M., Hale, G. E., Fraser, I. S., Hughes, C. L. & Burger, H. G. Changes in serum antimüllerian hormone levels across the ovulatory menstrual cycle in late reproductive age. Menopause 18, 521–524 (2011).
  Article PubMed Google Scholar
• Sowers, M. et al. Anti-Müllerian hormone and inhibin B variability during normal menstrual cycles. Fertil. Steril. 94, 1482–1486 (2010).
  Article CAS PubMed Google Scholar
• Streuli, I. et al. Clinical uses of anti-Müllerian hormone assays: pitfalls and promises. Fertil. Steril. 91, 226–230 (2009).
  Article CAS PubMed Google Scholar
• Wunder, D. M., Bersinger, N. A., Yared, M., Kretschmer, R. & Birkhäuser, M. H. Statistically significant changes of antimüllerian hormone and inhibin levels during the physiologic menstrual cycle in reproductive age women. Fertil. Steril. 89, 927–933 (2008).
  Article CAS PubMed Google Scholar
• Fanchin, R. et al. High reproducibility of serum anti-Mullerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status. Hum. Reprod. 20, 923–927 (2005).
  Article CAS PubMed Google Scholar
• Sowers, M. R. et al. Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. J. Clin. Endocrinol. Metab. 93, 3478–3483 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• van Disseldorp, J. et al. Relationship of serum antimüllerian hormone concentration to age at menopause. J. Clin. Endocrinol. Metab. 93, 2129–2134 (2008).
  Article CAS PubMed Google Scholar
• Broer, S. L. et al. Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women. J. Clin. Endocrinol. Metab. 96, 2532–2539 (2011).
  Article CAS PubMed Google Scholar
• Tehrani, F. R., Shakeri, N., Solaymani-Dodaran, M. & Azizi, F. Predicting age at menopause from serum antimüllerian hormone concentration. Menopause 18, 766–770 (2011).
  Article PubMed Google Scholar
• Tehrani, F. R., Solaymani-Dodaran, M. & Azizi, F. A single test of antimullerian hormone in late reproductive-aged women is a good predictor of menopause. Menopause 16, 797–802 (2009).
  Article PubMed Google Scholar
• Hendriks, D. J., Mol, B. W., Bancsi, L. F., Te Velde, E. R. & Broekmans, F. J. Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: a meta-analysis and comparison with basal follicle-stimulating hormone level. Fertil. Steril. 83, 291–301 (2005).
  Article PubMed Google Scholar
• Seifer, D. B., MacLaughlin, D. T., Christian, B. P., Feng, B. & Shelden, R. M. Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil. Steril. 77, 468–471 (2002).
  Article PubMed Google Scholar
• La Marca, A. et al. Anti-Müllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology. Hum. Reprod. 22, 766–771 (2007).
  Article CAS PubMed Google Scholar
• Nelson, S. M., Yates, R. W. & Fleming, R. Serum anti-Müllerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles—implications for individualization of therapy. Hum. Reprod. 22, 2414–2421 (2007).
  Article CAS PubMed Google Scholar
• Nelson, S. M. et al. Anti-Müllerian hormone-based approach to controlled ovarian stimulation for assisted conception. Hum. Reprod. 24, 867–875 (2009).
  Article CAS PubMed Google Scholar
• Broer, S. L. et al. AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis. Hum. Reprod. Update 17, 46–54 (2011).
  Article CAS PubMed Google Scholar
• Broer, S. L., Mol, B., Dolleman, M., Fauser, B. C. & Broekmans, F. J. The role of anti-Müllerian hormone assessment in assisted reproductive technology outcome. Curr. Opin. Obstet. Gynecol. 22, 193–201 (2010).
  Article PubMed Google Scholar
• Broer, S. L., Mol, B. W., Hendriks, D. & Broekmans, F. J. The role of antimüllerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertil. Steril. 91, 705–714 (2009).
  Article CAS PubMed Google Scholar
• Fadini, R. et al. Anti-mullerian hormone as a predictive marker for the selection of women for oocyte in vitro maturation treatment. J. Assist. Reprod. Genet. 28, 501–508 (2011).
  Article PubMed PubMed Central Google Scholar
• Gnoth, C. et al. Relevance of anti-Müllerian hormone measurement in a routine IVF program. Hum. Reprod. 23, 1359–1365 (2008).
  Article CAS PubMed Google Scholar
• Lie Fong, S. et al. Anti-Müllerian hormone: a marker for oocyte quantity, oocyte quality and embryo quality? Reprod. Biomed. Online 16, 664–670 (2008).
  Article CAS PubMed Google Scholar
• Smeenk, J. M. et al. Antimüllerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injection. Fertil. Steril. 87, 223–226 (2007).
  Article CAS PubMed Google Scholar
• La Marca, A. et al. Serum anti-müllerian hormone levels in women with secondary amenorrhea. Fertil. Steril. 85, 1547–1549 (2006).
  Article CAS PubMed Google Scholar
• Méduri, G. et al. Serum anti-Müllerian hormone expression in women with premature ovarian failure. Hum. Reprod. 22, 117–123 (2007).
  Article CAS PubMed Google Scholar
• Bachelot, A. et al. Phenotyping and genetic studies of 357 consecutive patients presenting with premature ovarian failure. Eur. J. Endocrinol. 161, 179–187 (2009).
  Article CAS PubMed Google Scholar
• Knauff, E. A. et al. Anti-Müllerian hormone, inhibin B, and antral follicle count in young women with ovarian failure. J. Clin. Endocrinol. Metab. 94, 786–792 (2009).
  Article CAS PubMed Google Scholar
• Sullivan, A. K. et al. Association of FMR1 repeat size with ovarian dysfunction. Hum. Reprod. 20, 402–412 (2005).
  Article CAS PubMed Google Scholar
• Rohr, J. et al. Anti-Mullerian hormone indicates early ovarian decline in fragile X mental retardation (FMR1) premutation carriers: a preliminary study. Hum. Reprod. 23, 1220–1225 (2008).
  Article CAS PubMed Google Scholar
• Spath, M. A. et al. Intra-individual stability over time of standardized anti-Müllerian hormone in FMR1 premutation carriers. Hum. Reprod. 26, 2185–2191 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Gleicher, N., Weghofer, A., Oktay, K. & Barad, D. H. Correlation of triple repeats on the FMR1 (fragile X) gene to ovarian reserve: a new infertility test? Acta Obstet. Gynecol. Scand. 88, 1024–1030 (2009).
  Article CAS PubMed Google Scholar
• Gleicher, N., Weghofer, A., Oktay, K. & Barad, D. Relevance of triple CGG repeats in the FMR1 gene to ovarian reserve. Reprod. Biomed. Online 19, 385–390 (2009).
  Article CAS PubMed Google Scholar
• Gleicher, N., Weghofer, A. & Barad, D. H. A pilot study of premature ovarian senescence: I. Correlation of triple CGG repeats on the FMR1 gene to ovarian reserve parameters FSH and anti-Müllerian hormone. Fertil. Steril. 91, 1700–1706 (2009).
  Article CAS PubMed Google Scholar
• Bennett, C. E., Conway, G. S., Macpherson, J. N., Jacobs, P. A. & Murray, A. Intermediate sized CGG repeats are not a common cause of idiopathic premature ovarian failure. Hum. Reprod. 25, 1335–1338 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Abir, R. et al. Turner's syndrome and fertility: current status and possible putative prospects. Hum. Reprod. Update 7, 603–610 (2001).
  Article CAS PubMed Google Scholar
• Toniolo, D. & Rizzolio, F. X chromosome and ovarian failure. Semin. Reprod. Med. 25, 264–271 (2007).
  Article CAS PubMed Google Scholar
• Borgström, B. et al. Fertility preservation in girls with turner syndrome: prognostic signs of the presence of ovarian follicles. J. Clin. Endocrinol. Metab. 94, 74–80 (2009).
  Article CAS PubMed Google Scholar
• Purushothaman, R., Lazareva, O., Oktay, K. & Ten, S. Markers of ovarian reserve in young girls with Turner's syndrome. Fertil. Steril. 94, 1557–1559 (2010).
  Article PubMed Google Scholar
• Tsigkou, A. et al. High serum inhibin concentration discriminates autoimmune oophoritis from other forms of primary ovarian insufficiency. J. Clin. Endocrinol. Metab. 93, 1263–1269 (2008).
  Article CAS PubMed Google Scholar
• La Marca, A. et al. Primary ovarian insufficiency due to steroidogenic cell autoimmunity is associated with a preserved pool of functioning follicles. J. Clin. Endocrinol. Metab. 94, 3816–3823 (2009).
  Article CAS PubMed Google Scholar
• Gleicher, N., Weghofer, A. & Barad, D. H. A pilot study of premature ovarian senescence: II. Different genotype and phenotype for genetic and autoimmune etiologies. Fertil. Steril. 91, 1707–1711 (2009).
  Article CAS PubMed Google Scholar
• Clowse, M. E. et al. Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis. J. Womens Health 18, 311–319 (2009).
  Article Google Scholar
• Nitzschke, M. et al. GnRH analogs do not protect ovaries from chemotherapy-induced ultrastructural injury in Hodgkin's lymphoma patients. Arch. Gynecol. Obstet. 282, 83–88 (2010).
  Article CAS PubMed Google Scholar
• Sánchez-Serrano, M. et al. Twins born after transplantation of ovarian cortical tissue and oocyte vitrification. Fertil. Steril. 93, 268.e11–268.e13 (2010).
  Article Google Scholar
• Meirow, D. et al. Monitoring the ovaries after autotransplantation of cryopreserved ovarian tissue: endocrine studies, in vitro fertilization cycles, and live birth. Fertil. Steril. 87, 418.e7–418.e15 (2007).
  Article Google Scholar
• Janse, F. et al. Limited value of ovarian function markers following orthotopic transplantation of ovarian tissue after gonadotoxic treatment. J. Clin. Endocrinol. Metab. 96, 1136–1144 (2011).
  Article CAS PubMed Google Scholar
• Schmidt, K. T. et al. Autotransplantation of cryopreserved ovarian tissue in 12 women with chemotherapy-induced premature ovarian failure: the Danish experience. Fertil. Steril. 95, 695–701 (2011).
  Article PubMed Google Scholar
• Lie Fong, S. et al. Assessment of ovarian reserve in adult childhood cancer survivors using anti-Müllerian hormone. Hum. Reprod. 24, 982–990 (2009).
  Article CAS PubMed Google Scholar
• Rosendahl, M. et al. Ovarian function after removal of an entire ovary for cryopreservation of pieces of cortex prior to gonadotoxic treatment: a follow-up study. Hum. Reprod. 23, 2475–2483 (2008).
  Article PubMed Google Scholar
• van Beek, R. D. et al. Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood. J. Clin. Endocrinol. Metab. 92, 3869–3874 (2007).
  Article CAS PubMed Google Scholar
• Bath, L. E., Wallace, W. H., Shaw, M. P., Fitzpatrick, C. & Anderson, R. A. Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Müllerian hormone, inhibin B and ovarian ultrasound. Hum. Reprod. 18, 2368–2374 (2003).
  Article CAS PubMed Google Scholar
• Lie Fong, S. et al. Anti-müllerian hormone as a marker of ovarian function in women after chemotherapy and radiotherapy for haematological malignancies. Hum. Reprod. 23, 674–678 (2008).
  Article CAS PubMed Google Scholar
• Su, H. I. et al. Antimullerian hormone and inhibin B are hormone measures of ovarian function in late reproductive-aged breast cancer survivors. Cancer 116, 592–599 (2010).
  Article CAS PubMed Google Scholar
• Partridge, A. H. et al. Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer. Fertil. Steril. 94, 638–644 (2010).
  Article PubMed Google Scholar
• Lutchman Singh, K. et al. Predictors of ovarian reserve in young women with breast cancer. Br. J. Cancer 96, 1808–1816 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Anderson, R. A., Themmen, A. P., Al-Qahtani, A., Groome, N. P. & Cameron, D. A. The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer. Hum. Reprod. 21, 2583–2592 (2006).
  Article CAS PubMed Google Scholar
• Yu, B. et al. Changes in markers of ovarian reserve and endocrine function in young women with breast cancer undergoing adjuvant chemotherapy. Cancer 116, 2099–2105 (2010).
  CAS PubMed Google Scholar
• Rosendahl, M. et al. Dynamics and mechanisms of chemotherapy-induced ovarian follicular depletion in women of fertile age. Fertil. Steril. 94, 156–166 (2010).
  Article CAS PubMed Google Scholar
• Anders, C. et al. A pilot study of predictive markers of chemotherapy-related amenorrhea among premenopausal women with early stage breast cancer. Cancer Invest. 26, 286–295 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Anderson, R. A. & Cameron, D. A. Pretreatment serum anti-müllerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer. J. Clin. Endocrinol. Metab. 96, 1336–1343 (2011).
  Article CAS PubMed Google Scholar
• Kaipia, A. & Hsueh, A. J. Regulation of ovarian follicle atresia. Annu. Rev. Physiol. 59, 349–363 (1997).
  Article CAS PubMed Google Scholar
• Massagué, J. TGF-β signal transduction. Annu. Rev. Biochem. 67, 753–791 (1998).
  Article PubMed Google Scholar
• Massagué, J. & Wotton, D. Transcriptional control by the TGF-beta/Smad signaling system. Embo. J. 19, 1745–1754 (2000).
  Article PubMed PubMed Central Google Scholar
• Visser, J. A. AMH signaling: from receptor to target gene. Mol. Cell. Endocrinol. 211, 65–73 (2003).
  Article CAS PubMed Google Scholar
• Erickson, G. F. & Shimasaki, S. The spatiotemporal expression pattern of the bone morphogenetic protein family in rat ovary cell types during the estrous cycle. Reprod. Biol. Endocrinol. 1, 9 (2003).
  Article PubMed PubMed Central Google Scholar